Trials / Completed
CompletedNCT04003194
Pinto Beans and Glycemic Control in Adults With Type 2 Diabetes
Impact of Pinto Beans as Part of a Normal Diet on Glycemic Control in Adults With Type 2 Diabetes: a Randomized Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- University of Colorado, Colorado Springs · Academic / Other
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study examines the impact of daily consumption of ½ c pinto beans, compared to a control (½ c green beans), on fasting glucose, postprandial glucose and HbA1c concentrations in adults with type 2 diabetes mellitus (T2DM).
Detailed description
This study utilized a randomized, pretest-posttest, crossover (within-group) design, that includes two treatment periods \[control period (½ c. green beans each day) and pinto beans (½ c each day)\], each 12-weeks in duration with a 4- week wash-out period to determine the impact on fasting glucose, postprandial glucose and HbA1c concentrations. After a baseline wash-in period, 16 participants are randomly assigned to 2 treatment periods \[control period and pinto beans\], each 12-weeks in duration. On 28 randomized days during the wash-in period and interventions, participants keep diet records and measure a postprandial capillary glucose concentration using a glucometer 1 hour after the meal during which the pinto beans or control are consumed. Before and after each 12-week intervention, participants provide a fasted venous blood sample for glucose and HbA1c analyses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pinto Beans | The intervention was 1/2 cup of pinto beans each day. |
| OTHER | Green Beans - control | The control was 1/2 cup of green beans each day. |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2010-12-31
- Completion
- 2010-12-31
- First posted
- 2019-07-01
- Last updated
- 2019-07-01
Source: ClinicalTrials.gov record NCT04003194. Inclusion in this directory is not an endorsement.